Scinder Pharmaceuticals Private Limited

Scinder Pharmaceuticals Private Limited - trading in New Delhi, Delhi, India. FY 2026 financials and compliance.
CIN U51101DL2015PTC281891 Incorporated 23 June 2015 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2023
₹5.24 Lakh
▼ 10.00% YoY
EBITDA · FY 2023
Locked
In full report
Net profit · FY 2023
Locked
In full report
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
11 yrs
Est. 2015
Last financials
Mar 2023
Balance sheet date

About Scinder Pharmaceuticals Private Limited

Data last updated: 25 February 2026

Scinder Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It specialises in wholesale trading and distribution, a part of the broader trading and commerce sector. Incorporated on 23 June 2015, the company has been in operation for over 11 years.

Registered with ROC Delhi under CIN U51101DL2015PTC281891.

Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mahak Ruhela and Nitesh Rohilla.

Last AGM: 30 September 2023. Financial statements filed for year ended 31 March 2023. Office: 9 – A Shivpuri Road Shivpuri Extension, New Delhi, Delhi, India – 110051.

As per the financials filed for FY 2023, the company reported a revenue of ₹5.24 Lakh, a decline of 10% compared to the previous year.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Scinder Pharmaceuticals Private Limited
CIN U51101DL2015PTC281891
Registration Number 281891
Incorporation Date 23 June 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    9 – A Shivpuri Road Shivpuri Extension, New Delhi, Delhi, India – 110051
  • Industry
    Trading, Wholesale, Other Wholesale
Company report
Scinder Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Scinder Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Scinder Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Scinder Pharmaceuticals Private Limited

Scinder Pharmaceuticals Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Scinder Pharmaceuticals Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Scinder Pharmaceuticals Private Limited

Scinder Pharmaceuticals Private Limited is audited by SVP&ASSOCIATES for the financial year 2017. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
SVP&ASSOCIATES Locked Locked Locked
Premium access

Complete auditor history for Scinder Pharmaceuticals Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Scinder Pharmaceuticals Private Limited

Scinder Pharmaceuticals Private Limited is currently managed by 2 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Mahak Ruhela Director 18 Sep 2020 5 Years 11 Months Current
Nitesh Rohilla Director 23 Jun 2015 11 Years 2 Months Current

Financials of Scinder Pharmaceuticals Private Limited FY 2023 filings available

Scinder Pharmaceuticals Private Limited reported revenue of ₹5.24 Lakh (down 10.00% YoY) for FY 2023.

Revenue · FY 2023
₹5.24 Lakh ▼ 10.00%
Premium access

Ten-year financial statements for Scinder Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Scinder Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Scinder Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Scinder Pharmaceuticals Private Limited

Scinder Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Scinder Pharmaceuticals Private Limited

View historical data on people associated with Scinder Pharmaceuticals Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Scinder Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Scinder Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Scinder Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Scinder Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Scinder Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Scinder Pharmaceuticals Private Limited

Premium access

MSME payment history for Scinder Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Scinder Pharmaceuticals Private Limited

Premium access

Corporate group structure for Scinder Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Scinder Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Scinder Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Scinder Pharmaceuticals Private Limited

Activity
30 Sep 2023
Scinder Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Activity
31 Mar 2023
Scinder Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi I.
Directors
18 Sep 2020
Mahak Ruhela was appointed as a Director on 18 Sep 2020 & has been associated with this company since 5 years 11 months.
Directors
23 Jun 2015
Nitesh Rohilla was appointed as a Director on 23 Jun 2015 & has been associated with this company since 11 years 2 months.
Activity
23 Jun 2015
Scinder Pharmaceuticals Private Limited was registered on 23 Jun 2015 with Roc Delhi I & aged 11 years 2 months as per MCA records.

Frequently Asked Questions about Scinder Pharmaceuticals Private Limited

Scinder Pharmaceuticals Private Limited is an active private limited company in the trading sector based in New Delhi, Delhi, India. It was incorporated on 23 June 2015 (11+ years old) and is registered under CIN U51101DL2015PTC281891.

Scinder Pharmaceuticals Private Limited reported revenue of ₹5.24 Lakh for FY 2023 (down 10.00% YoY).

The current directors of Scinder Pharmaceuticals Private Limited are:

The primary industry of Scinder Pharmaceuticals Private Limited is trading. The company specifically operates in wholesale. The company is currently active in this sector.

Scinder Pharmaceuticals Private Limited can be reached at the registered office: 9 – A Shivpuri Road Shivpuri Extension, New Delhi, Delhi, India – 110051.

The authorised capital is ₹1 Lakh, and the paid-up capital is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available